Antiparasitic GABA-Cl channel inhibitor specifically targeting Demodex mites on the lid margin. FDA-approved 2023 for Demodex blepharitis.
Specifications
specific products available under the Lotilaner treatment
Product
Manufacturer
Xdemvy 0.25%
Tarsus Pharmaceuticals
Not medical advice. Patient-reported data on this page is aggregated from de-identified user submissions and is for informational purposes only. Always consult your ophthalmologist or optometrist about starting, stopping, or changing any treatment.